So Barno - this £140m is based on your detailed analysis of the Mexican betting market and all the other income (ha!) streams for our company and in no way is just 10 times what someone gave as our MCap in the previous post. That's right isn't it?
I bought Reneuron along with Summit on the same day about maybe 8 years back. I'd always bracketed them together in my mind as companies that would conquer disease and make me a few bob. Turns out I was half right - shame that Summit had to leave the UK and rely on a US billionaire to do it.
"I did make a fair few quid on this when I sold." There you go then - what a terrible company and terrible share this must be. Everybody could have made fair returns if they sold on 6 June last year. Maybe some did - maybe it was you Davand! - and, obvs, some didn't. I would have made around 150 per cent but didn't. Either way this Tucker Suckers stuff is sub-par keyboard warrior bilge. The company has being doing well until an usually large bump in the road.
So I received a news release from Summit at 06.32 today (Saturday) - weird. More excitement anyway - this time about the Harmoni A trial, separate from the Harmoni-2 trial - I won't pretend to understand it in any kind of detail but the words 'Showed Clinically Meaningful and Statistically Significant Benefit' seem relevant :-). Monday morning /afternoon could be rather interesting.
Always hard to argue against taking a profit, but...remember Keytruda has sales of $25 billion a year. We don't have rights to all markets but if we really do outperform it, and that's what we're saying, then that's a mighty big market to chip away at. I think there's good reason to hold for sometime yet.
Well we've got our statement. I suppose that's as much as we can expect at this stage, and I fear this may rumble on a bit. From the highly informed viewpoint of a bloke sitting in an armchair in Leicester, I expect there are both political rivalries and pressures such as kickback on the policy from some in the fishing community to factor in, not just any sharp practice there may or may not have been in the awarding of the contract.
"When was the last time you saw a Greggs without a queue?". This was my entire investment case when I first bought in here as a novice investor at just over 500p. The only other share I've made good money on was ARM, which I bought in the early 2000s because these mobile phone things looked they were popular. Can't honestly say this approach is foolproof but it seems a decent strategy.
52-week high today - let's hope this is finally the recognition that we have moved into profit and appear likely to steadily improve for some time to come. Experience suggests caution but I can't see any reason why we should fall back significantly.
Blimey. That seems a major development.
Just caught the end of a feature on tidal on BBC News, including a bit of film attributed to us. Film seemed a bit sceptical that tidal would ever be more than a minor backup to other forms of energy but good to be in the news anyway.
Free Investment Tools
Register for FREE